Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PGD2 effects on rodent behavior and EEG patterns in cats

S G Laychock, D N Johnson, L S Harris

    Pharmacology, Biochemistry, and Behavior
    |May 1, 1980
    PubMed
    Summary

    Prostaglandin D2 (PGD2) exhibits sedative effects on the central nervous system, reducing activity in rodents and altering brain waves in cats. While PGD2 did not affect neuromuscular coordination or prevent seizures, it induced sedation and other physiological changes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Utility of BRAF V600E immunohistochemistry in the diagnosis of mandibular ameloblastomas.

    International journal of oral and maxillofacial surgery·2023
    Same author

    Simulating microbial processes in extraterrestrial, aqueous environments.

    Journal of microbiological methods·2020
    Same author

    Concurrent fungus ball and squamous cell carcinoma of the maxillary sinus.

    European annals of otorhinolaryngology, head and neck diseases·2016
    Same author

    Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice.

    Psychopharmacology·2012
    Same author

    Benzomorphans. Optically Active and trans Isomers.

    Journal of medicinal chemistry·2011
    Same author

    Sphingosine kinase 1 knockdown reduces insulin synthesis and secretion in a rat insulinoma cell line.

    Archives of biochemistry and biophysics·2011

    Area of Science:

    • Neuropharmacology
    • Central Nervous System Research

    Background:

    • Prostaglandin D2 (PGD2) is a lipid compound with various physiological roles.
    • Its specific effects on the central nervous system (CNS) require detailed investigation.

    Purpose of the Study:

    • To elucidate the pharmacological actions of Prostaglandin D2 within the central nervous system.
    • To assess the sedative and neurological impact of PGD2 in animal models.

    Main Methods:

    • Administration of varying doses of PGD2 to rats and mice to measure locomotor activity and pentobarbital-induced sleep.
    • Evaluation of neuromuscular coordination in mice post-PGD2 treatment.
    • EEG monitoring in cats following PGD2 infusion to observe central nervous system responses.
    • Assessment of PGD2's efficacy in preventing electroshock and pentylenetetrazol-induced convulsions.

    Related Experiment Videos

    Main Results:

    • PGD2 significantly decreased spontaneous locomotor activity in rats (up to 66%) but did not impair neuromuscular coordination in mice.
    • A dose-dependent increase in pentobarbital sleeping time was observed in mice (42%–238%).
    • EEG studies in cats showed a characteristic shift from low-voltage, fast-wave to high-voltage, slow-wave patterns, indicative of sedation. Higher doses also caused hypotension, bradycardia, diarrhea, analgesia, and hyperthermia.

    Conclusions:

    • Prostaglandin D2 demonstrates notable sedative properties in both rodents and cats.
    • PGD2's effects on the central nervous system suggest a potential role in neurological functions and sedation.